FDA approves expanded use of Bristol-Myers' drug for lung cancer
October 09, 2015 at 14:25 PM EDT
Oct 9 (Reuters) - The U.S. Food and Drug Administration approved the expanded use of Bristol-Myers Squibb Co's immunotherapy Opdivo to treat patients with advanced non-small cell lung cancer.
